IL6 and viral infectious disease: Of the different cytokines that increase and reach such an exacerbated response [70], Interleukin-6 (IL-6) in serum is mainly expected to predict SARS-CoV-2 pneumonia severity as the suppression of pro-inflammatory IL-6 has been demonstrated to have a therapeutic effect on many inflammatory diseases, including viral infections [71].